{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:56:49Z","timestamp":1794956209474,"version":"4.9.1"},"reference-count":86,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T00:00:00Z","timestamp":1211932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Pure red cell aplasia (PRCA) is a syndrome characterized by a severe normocytic anaemia, reticulocytopenia, and absence of erythroblasts from an otherwise normal bone marrow. Primary PRCA, or secondary PRCA which has not responded to treatment of the underlying disease, is treated as an immunologically\u2010mediated disease. Although vigorous immunosuppressive treatments induce and maintain remissions in a majority of patients, they carry an increased risk of serious complications. Corticosteroids were used in the treatment of PRCA and this has been considered the treatment of first choice although relapse is not uncommon. Cyclosporine A (CsA) has become established as one of the leading drugs for treatment of PRCA. However, common concerns have been the number of patients treated with CsA who achieve sustained remissions and the number that relapse. This article reviews the current status of CsA therapy and compares it to other treatments for diverse PRCAs.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07216.x","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T15:55:50Z","timestamp":1211990150000},"page":"505-514","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["Acquired pure red cell aplasia: updated review of treatment"],"prefix":"10.1111","volume":"142","author":[{"given":"Kenichi","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,5,28]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830230408"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.2.103"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1986.tb01779.x"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.36892.x"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04613.x"},{"key":"e_1_2_3_7_1","first-page":"559","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants","volume":"5","author":"Bladford L.D.","year":"2004","journal-title":"Pharmacogenomics"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011931"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.161"},{"key":"e_1_2_3_10_1","first-page":"197","volume-title":"T\u2010Cell Large Granular Lymphocyte Leukaemia: World Health Organization Classification of Tumours. Tumours of Haematopoietic and Lymphoid Tissues","author":"Chan W.C.","year":"2001"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.11.4831.bloodjournal87114831"},{"key":"e_1_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V63.2.277.277"},{"key":"e_1_2_3_13_1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1001\/jama.1986.03370170079039","article-title":"Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow\u2010up study","volume":"255","author":"Csuka M.","year":"1986","journal-title":"The Journal of the American Medical Association"},{"key":"e_1_2_3_14_1","volume-title":"Pure Red Cell Aplasia","author":"Dessypris E.N.","year":"1988"},{"key":"e_1_2_3_15_1","first-page":"1421","volume-title":"Wintrobe\u2019s Clinical Hematology","author":"Dessypris E.N.","year":"2004"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1620.1620"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-006-0202-5"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb01183.x"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02429.x"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-12-926"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420229"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70431-8"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.1092"},{"key":"e_1_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.2.483"},{"key":"e_1_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(03)00140-9"},{"key":"e_1_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350505"},{"key":"e_1_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402676"},{"key":"e_1_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/146532401753174098"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00406-X"},{"key":"e_1_2_3_30_1","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V100.6.2260","article-title":"Rituximab treatment of refractory fludarabine\u2010associated immune thrombocytopenia in chronic lymphocytic leukemia","volume":"100","author":"Hegde U.P.","year":"2002","journal-title":"Blood"},{"key":"e_1_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2923"},{"key":"e_1_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11655"},{"key":"e_1_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.12.3872"},{"key":"e_1_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"e_1_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20200"},{"key":"e_1_2_3_36_1","first-page":"557","article-title":"Zur Entstehung der Blutpl\u00e4ttchen","volume":"34","author":"Kaznelson P.","year":"1922","journal-title":"Verhandlungen der Deutschen Gesellschaft Fur Innere Medizin"},{"key":"e_1_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3554"},{"key":"e_1_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.58.2.493"},{"key":"e_1_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.7.3000.bloodjournal8773000"},{"key":"e_1_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327489800500103"},{"key":"e_1_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(03)00133-1"},{"key":"e_1_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211"},{"key":"e_1_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198709000-00005"},{"key":"e_1_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.1.72.72"},{"key":"e_1_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.7.2164.2164"},{"key":"e_1_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1997.tb00978.x"},{"key":"e_1_2_3_47_1","first-page":"285","article-title":"Therapy of pure red cell aplasia","volume":"28","author":"Marmont A.M.","year":"1991","journal-title":"Seninars in Hematology"},{"key":"e_1_2_3_48_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood.V45.2.247.247","article-title":"Pure red cell aplasia (PRCA): response of three patients of cyclophosphamide and\/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis","volume":"45","author":"Marmont A.","year":"1975","journal-title":"Blood"},{"key":"e_1_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb04392.x"},{"key":"e_1_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<164::AID-AJH16>3.0.CO;2-4"},{"key":"e_1_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.05.017"},{"key":"e_1_2_3_52_1","first-page":"617","article-title":"Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature","volume":"2","author":"Oshimi K.","year":"1988","journal-title":"Leukemia"},{"key":"e_1_2_3_53_1","first-page":"782","article-title":"Laboratory findings and clinical courses of 33 patients with granular lymphocyte\u2010proliferative disorders","volume":"7","author":"Oshimi K.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22032"},{"key":"e_1_2_3_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200554"},{"key":"e_1_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06573-4"},{"key":"e_1_2_3_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380815"},{"key":"e_1_2_3_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02076698"},{"key":"e_1_2_3_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05250.x"},{"key":"e_1_2_3_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J"},{"key":"e_1_2_3_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000107561.59698.42"},{"key":"e_1_2_3_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1090"},{"key":"e_1_2_3_63_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04609.x"},{"key":"e_1_2_3_64_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11192"},{"key":"e_1_2_3_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871215)60:12<2971::AID-CNCR2820601220>3.0.CO;2-O"},{"key":"e_1_2_3_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.1.256"},{"key":"e_1_2_3_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.1184.015k54_1184_1186"},{"key":"e_1_2_3_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206939"},{"key":"e_1_2_3_69_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03778.x"},{"key":"e_1_2_3_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.9.3372"},{"key":"e_1_2_3_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.4.952"},{"key":"e_1_2_3_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015818"},{"key":"e_1_2_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(03)00061-1"},{"key":"e_1_2_3_74_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-050526"},{"key":"e_1_2_3_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06295.x"},{"key":"e_1_2_3_76_1","first-page":"694","article-title":"Successful treatment of pure red cell aplasia with cyclosporine","volume":"2","author":"Totterman T.H.","year":"1984","journal-title":"Lancet"},{"key":"e_1_2_3_77_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1989.tb01201.x"},{"key":"e_1_2_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16302-2"},{"key":"e_1_2_3_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000027031.79843.6C"},{"key":"e_1_2_3_80_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03039.x"},{"key":"e_1_2_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70021-1"},{"key":"e_1_2_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.05.007"},{"key":"e_1_2_3_83_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.282672.x"},{"key":"e_1_2_3_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-03-010777"},{"key":"e_1_2_3_85_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb01874.x"},{"key":"e_1_2_3_86_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3995"},{"key":"e_1_2_3_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)63116-5"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07216.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07216.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T09:29:16Z","timestamp":1734427756000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07216.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,28]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07216.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07216.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,28]]},"assertion":[{"value":"2008-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}